Assesses Noonan syndrome features including pulmonary stenosis severity, HCM risk, bleeding disorder (von Willebrand, platelet dysfunction), short stature SDS, and MEK/RAS pathway mutation for trametinib eligibility.
Enter the values for the scenario you are assessing. Assesses Noonan syndrome features including pulmonary stenosis severity, HCM risk, bleeding disorder (von Willebrand, platelet dysfunction), short stature SDS, and MEK/RAS pathway mutation for trametinib eligibility. Use the noonan syndrome score result to inform your calculation.